Add To...

    CHTP  Chelsea Therapeutics Internati...

    Exchange

    NASDAQ

    Sector

    Health Care

    Industry

    Biotechnology: Biological Products (No Diagnostic Substances)

    Market Cap.

    123.4M

    Very Strong Balance Sheet

    CHTP has more Cash than its Total Liabilities, resulting in $0.54 Net Cash per share. In other words, if you buy CHTP today, the price you're paying for shares is actually $1.30 because $0.54 of Cash is included in the current share price. This much Cash is very healthy. It can help CHTP sustain itself in the face of any economic turmoil and makes a stock buyback more of a possibility.
    Figures in USD. Fiscal year ends in December
    20042005200620072008200920102011
    Cash - - 15.90M 62.71M 31.84M 33.74M 47.59M 45.61M
    Current Assets - - 16.11M 63.11M 32.57M 34.17M 48.16M 46.57M
    Total Assets - - 16.17M 63.16M 44.13M 34.35M 48.37M 46.90M
    Current Liabilities 24,471.00 40,975.00 2.03M 5.20M 12.31M 21.50M 13.19M 13.24M
    Total Liabilities 24,471.00 40,975.00 2.03M 5.20M 19.58M 21.50M 13.19M 13.24M
    Stockholder' Equity -24,471.00 -40,975.00 14.14M 57.97M 24.55M 12.85M 35.19M 33.66M
    Current Ratio - - 7.92 12.14 2.65 1.59 3.65 3.52
    TL-to-TA - - 0.13 0.08 0.44 0.63 0.27 0.28

    Low or No Reinvestment of Profits over the past 8 years

    CHTP has either been retaining a small amount of their earnings or has done so inconsistently. A lack of consistency could be due to CHTP operating at a loss or them having such a strong economic moat they feel comfortable spending profits on growth. Be wary of future prospects and if applicable, inspect the moat's sustainability.
    Figures in USD. Fiscal year ends in December
    20042005200620072008200920102011
    Retained Earnings -145,331.00 -161,835.00 -19.60M -34.69M -69.77M -95.54M -132.87M -183.33M
    Retained Earnings Growth - -11.36% -12,013.36% -76.93% -101.16% -36.94% -39.07% -37.97%